Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
468K
-
Shares change
-
+164K
-
Total reported value, excl. options
-
$2.97M
-
Value change
-
+$2.08M
-
Number of buys
-
14
-
Number of sells
-
-4
-
Price
-
$6.44
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q3 2018
21 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q3 2018.
IGC Pharma, Inc. - COM NEW (IGC) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 468K shares
.
Largest 10 shareholders include Carroll Financial Associates, Inc. (215K shares), Creative Planning (65K shares), HSBC HOLDINGS PLC (59.7K shares), SUNTRUST BANKS INC (55K shares), JANE STREET GROUP, LLC (21.3K shares), ING GROEP NV (15K shares), Cambridge Investment Research Advisors, Inc. (11.7K shares), CenterStar Asset Management, LLC (6.5K shares), Advisor Group, Inc. (5.23K shares), and CITIGROUP INC (3K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.